{"id":"https://openalex.org/W2068292467","doi":"https://doi.org/10.1158/1535-7163.mct-06-0048","title":"Antiangiogenic activity of 4\u2032-thio-\u03b2- d -arabinofuranosylcytosine","display_name":"Antiangiogenic activity of 4\u2032-thio-\u03b2- d -arabinofuranosylcytosine","publication_year":2006,"publication_date":"2006-09-01","ids":{"openalex":"https://openalex.org/W2068292467","doi":"https://doi.org/10.1158/1535-7163.mct-06-0048","mag":"2068292467","pmid":"https://pubmed.ncbi.nlm.nih.gov/16985055"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-06-0048","doi":"https://doi.org/10.1158/1535-7163.mct-06-0048","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-06-0048","pdf_url":"https://aacrjournals.org/mct/article-pdf/5/9/2218/1874190/2218.pdf","source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aacrjournals.org/mct/article-pdf/5/9/2218/1874190/2218.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052998843","display_name":"Anshu Mittal Roy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I108109523","display_name":"Southern Research Institute","ror":"https://ror.org/0153ngy95","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I108109523"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anshu M. Roy","raw_affiliation_strings":["Drug Discovery Division, Southern Research Institute, Birmingham, Alabama"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Division, Southern Research Institute, Birmingham, Alabama","institution_ids":["https://openalex.org/I108109523"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103413950","display_name":"Kamal N. Tiwari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I108109523","display_name":"Southern Research Institute","ror":"https://ror.org/0153ngy95","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I108109523"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kamal N. Tiwari","raw_affiliation_strings":["Drug Discovery Division, Southern Research Institute, Birmingham, Alabama"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Division, Southern Research Institute, Birmingham, Alabama","institution_ids":["https://openalex.org/I108109523"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064978721","display_name":"William B. Parker","orcid":"https://orcid.org/0000-0002-7387-939X","observed_orcids":["https://orcid.org/0000-0002-7387-939X"]},"institutions":[{"id":"https://openalex.org/I108109523","display_name":"Southern Research Institute","ror":"https://ror.org/0153ngy95","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I108109523"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William B. Parker","raw_affiliation_strings":["Drug Discovery Division, Southern Research Institute, Birmingham, Alabama"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Division, Southern Research Institute, Birmingham, Alabama","institution_ids":["https://openalex.org/I108109523"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074182580","display_name":"John A. III Secrist","orcid":"https://orcid.org/0000-0003-3431-8482","observed_orcids":["https://orcid.org/0000-0003-3431-8482"]},"institutions":[{"id":"https://openalex.org/I108109523","display_name":"Southern Research Institute","ror":"https://ror.org/0153ngy95","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I108109523"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John A. Secrist","raw_affiliation_strings":["Drug Discovery Division, Southern Research Institute, Birmingham, Alabama"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Division, Southern Research Institute, Birmingham, Alabama","institution_ids":["https://openalex.org/I108109523"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000514275","display_name":"Rongbao Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I108109523","display_name":"Southern Research Institute","ror":"https://ror.org/0153ngy95","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I108109523"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rongbao Li","raw_affiliation_strings":["Drug Discovery Division, Southern Research Institute, Birmingham, Alabama"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Division, Southern Research Institute, Birmingham, Alabama","institution_ids":["https://openalex.org/I108109523"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002938075","display_name":"Zhican Qu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I108109523","display_name":"Southern Research Institute","ror":"https://ror.org/0153ngy95","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I108109523"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhican Qu","raw_affiliation_strings":["Drug Discovery Division, Southern Research Institute, Birmingham, Alabama"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery Division, Southern Research Institute, Birmingham, Alabama","institution_ids":["https://openalex.org/I108109523"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I108109523"],"apc_list":null,"apc_paid":null,"fwci":0.2717,"has_fulltext":true,"cited_by_count":14,"citation_normalized_percentile":{"value":0.54571619,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"5","issue":"9","first_page":"2218","last_page":"2224"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Synthesis and biological activity","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cytarabine","display_name":"cytarabine","score":0.8429999947547913},{"id":"https://openalex.org/keywords/antiangiogenic-activity","display_name":"antiangiogenic activity","score":0.9419999718666077},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.6769999861717224},{"id":"https://openalex.org/keywords/endothelial-cell-migration","display_name":"endothelial cell migration","score":0.7699999809265137},{"id":"https://openalex.org/keywords/erk1-2-phosphorylation","display_name":"ERK1/2 phosphorylation","score":0.9670000076293945},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.9160000085830688},{"id":"https://openalex.org/keywords/chick-chorioallantoic-membrane-assay","display_name":"chick chorioallantoic membrane assay","score":0.8159999847412109}],"concepts":[{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.7925816774368286},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7351405620574951},{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.6129293441772461},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5320544838905334},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.49357903003692627},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.46574389934539795},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.41979825496673584},{"id":"https://openalex.org/C2776120743","wikidata":"https://www.wikidata.org/wiki/Q3271540","display_name":"Mechanism of action","level":3,"score":0.412638783454895},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3625432848930359},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2412620186805725},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2364434003829956},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001087","descriptor_name":"Arabinonucleosides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002642","descriptor_name":"Chick Embryo","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000098","qualifier_name":"blood supply","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D018919","descriptor_name":"Neovascularization, Physiologic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019950","descriptor_name":"Mitogen-Activated Protein Kinase 1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D019950","descriptor_name":"Mitogen-Activated Protein Kinase 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D042783","descriptor_name":"Endothelial Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048052","descriptor_name":"Mitogen-Activated Protein Kinase 3","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D048052","descriptor_name":"Mitogen-Activated Protein Kinase 3","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D049033","descriptor_name":"Chorioallantoic Membrane","qualifier_ui":"Q000098","qualifier_name":"blood supply","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.mct-06-0048","doi":"https://doi.org/10.1158/1535-7163.mct-06-0048","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-06-0048","pdf_url":"https://aacrjournals.org/mct/article-pdf/5/9/2218/1874190/2218.pdf","source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:16985055","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16985055","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.mct-06-0048","doi":"https://doi.org/10.1158/1535-7163.mct-06-0048","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-06-0048","pdf_url":"https://aacrjournals.org/mct/article-pdf/5/9/2218/1874190/2218.pdf","source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9789000153541565}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2068292467.pdf","grobid_xml":"https://content.openalex.org/works/W2068292467.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W105317665","https://openalex.org/W267359167","https://openalex.org/W1516603921","https://openalex.org/W1562405218","https://openalex.org/W1599244262","https://openalex.org/W1764262042","https://openalex.org/W1971237693","https://openalex.org/W1981774762","https://openalex.org/W1988524161","https://openalex.org/W1997112174","https://openalex.org/W2007328999","https://openalex.org/W2012327618","https://openalex.org/W2024215957","https://openalex.org/W2030984044","https://openalex.org/W2035996742","https://openalex.org/W2036765487","https://openalex.org/W2046553666","https://openalex.org/W2070760814","https://openalex.org/W2076163424","https://openalex.org/W2082415645","https://openalex.org/W2088982851","https://openalex.org/W2107533401","https://openalex.org/W2109197670","https://openalex.org/W2109572137","https://openalex.org/W2152610325","https://openalex.org/W2154116703","https://openalex.org/W2321152392","https://openalex.org/W2341116212","https://openalex.org/W2404570267","https://openalex.org/W2804842145","https://openalex.org/W4210685869","https://openalex.org/W4250106116"],"related_works":["https://openalex.org/W7097934605","https://openalex.org/W2024215957","https://openalex.org/W2046553666","https://openalex.org/W1599244262","https://openalex.org/W7100897350","https://openalex.org/W2095023058","https://openalex.org/W2056569963","https://openalex.org/W2343803828","https://openalex.org/W2007328999","https://openalex.org/W2014120566"],"abstract_inverted_index":{"4'-Thio-beta-D-arabinofuranosylcytosine":[0],"(T-araC),":[1],"a":[2,26,32,135,177,196],"new-generation":[3],"deoxycytidine":[4],"nucleoside":[5],"analogue,":[6],"showed":[7,167],"significant":[8],"efficacy":[9,49,208],"against":[10,50,64,209],"numerous":[11],"solid":[12,51,65,86,211],"tumors":[13,66],"in":[14,36,59,69,85,97,100,140,163,181,192,206,227],"preclinical":[15],"studies":[16],"and":[17,91,99,119,183,189,222,237],"entered":[18],"clinical":[19,228],"development":[20,158],"for":[21,93,195,219],"cancer":[22],"therapy.":[23],"It":[24],"is":[25],"structural":[27],"analogue":[28],"of":[29,39,62,73,143,159,173,179,199,224],"cytarabine":[30],"(araC),":[31],"clinically":[33],"used":[34],"drug":[35,200],"the":[37,57,157,204],"treatment":[38],"acute":[40],"myelogenous":[41],"leukemia,":[42],"which":[43],"has":[44],"no":[45],"or":[46],"very":[47],"limited":[48],"tumors.":[52,87,212],"In":[53],"comparison":[54],"with":[55,109],"araC,":[56],"excellent":[58,205],"vivo":[60,207],"activity":[61,191],"T-araC":[63,76,90,114,124,154,180,186,225,232],"suggests":[67],"that,":[68],"addition":[70],"to":[71,202],"inhibition":[72],"DNA":[74],"synthesis,":[75],"may":[77],"target":[78],"cellular":[79,141],"signaling":[80,137],"pathways,":[81],"such":[82],"as":[83,233],"angiogenesis,":[84],"We":[88],"studied":[89],"araC":[92,166],"their":[94],"antiangiogenic":[95,190,239],"activities":[96],"vitro":[98],"vivo.":[101],"Both":[102],"compounds":[103],"inhibited":[104,115,156],"human":[105],"endothelial":[106,116,127],"cell":[107,117,128],"proliferation":[108],"similar":[110],"IC50s.":[111],"However,":[112],"only":[113],"migration":[118],"differentiation":[120],"into":[121],"capillary":[122],"tubules.":[123],"also":[125,215],"abrogated":[126],"extracellular":[129],"signal-regulated":[130],"kinase":[131],"(ERK)":[132],"1/2":[133],"phosphorylation,":[134],"key":[136],"molecule":[138,194],"involved":[139],"processes":[142],"angiogenesis.":[144],"Results":[145],"from":[146],"chick":[147],"chorioallantoic":[148],"membrane":[149],"angiogenesis":[150],"assays":[151],"revealed":[152],"that":[153,185],"significantly":[155],"new":[160],"blood":[161],"vessels":[162],"vivo,":[164],"whereas":[165],"much":[168],"less":[169],"effect.":[170],"The":[171],"findings":[172],"this":[174],"study":[175,214],"show":[176],"role":[178],"antiangiogenesis":[182],"suggest":[184],"combines":[187],"antiproliferative":[188,236],"one":[193],"dual":[197],"mechanism":[198],"action":[201],"achieve":[203],"several":[210],"This":[213],"provides":[216],"important":[217],"information":[218],"optimizing":[220],"dosage":[221],"sequence":[223],"administration":[226],"investigations":[229],"by":[230],"considering":[231],"both":[234],"an":[235,238],"agent.":[240]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}